Capital AllocationAZZ's focus on bolt-on M&A and share buybacks, coupled with a solid Net Debt/EBITDA target range, could yield over 20% return on invested capital.
Financial HealthAnalyst expects AZZ to rebrand as a quality-at-a-reasonable-price investment, with resilience across the business cycle and an improving competitive moat.
Market TrendsAZZ benefits from strong secular trends in favor of reshoring and infrastructure upgrades, along with a cyclical recovery in metals demand.